Open Label Randomized Study Evaluating the in Vivo Efficacies of Artemether-lumefantrine and Dihydroartemisinin-piperaquine in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Under Five Years of Age in Western Kenya
Latest Information Update: 01 Sep 2022
At a glance
- Drugs Artemether/lumefantrine (Primary) ; Dihydroartemisinin/piperaquine (Primary)
- Indications Falciparum malaria
- Focus Therapeutic Use
- 29 Aug 2022 Results assessing efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the treatment of uncomplicated plasmodium falciparum malaria among children in Western Kenya, published in the Antimicrobial Agents and Chemotherapy
- 01 Oct 2021 New trial record